- Home
- MDGL vs HAS Comparison
MDGL vs HAS Comparison
Compare MDGL & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | HAS |
|---|---|---|
| Founded | 2011 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 13.2B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MDGL | HAS |
|---|---|---|
| Price | $514.15 | $92.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $674.45 | $109.73 |
| AVG Volume (30 Days) | 277.0K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $180,133,000.00 | ★ $5,365,900,000.00 |
| Revenue This Year | $58.39 | $5.38 |
| Revenue Next Year | $48.55 | $6.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 13.06 |
| 52 Week Low | $265.00 | $60.33 |
| 52 Week High | $615.00 | $106.98 |
Technical Indicators
Market Signals| Indicator | MDGL | HAS |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 48.75 |
| Support Level | $503.93 | $92.16 |
| Resistance Level | $539.17 | $94.35 |
| Average True Range (ATR) | 16.05 | 3.11 |
| MACD | -3.60 | 0.20 |
| Stochastic Oscillator | 38.38 | 44.95 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.